Tocilizumab did not reduce hypoxemic respiratory...

Tocilizumab did not reduce hypoxemic respiratory failure or death in hospitalized patients with COVID-19.

Abstract

SOURCE CITATION: Stone JH, Frigault MJ, Serling-Boyd NJ, et al. Efficacy of tocilizumab in patients hospitalized with Covid-19. N Engl J Med. 2020;383:2333-44. 33085857.

Authors

Sharif S; Rochwerg B

Journal

Annals of Internal Medicine, Vol. 174, No. 2,

Publisher

American College of Physicians

Publication Date

February 1, 2021

DOI

10.7326/acpj202102160-016

ISSN

1056-8751

Associated Experts

Bram Rochwerg

Associate Professor, Faculty of Health Sciences

Visit profile

Sameer Sharif

Assistant Professor, FHSMED